Metraipolis › archive › dc_caf9e60bf478

Impact evaluation of the Hypertension Treatment in Nigeria program using the Translational Science Benefits Model — Europe PMC PMID:42534330

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42534330
DOI
10.1017/cts.2026.10790
License (as archived)
solo-consultazione
Archived
2026-10-18T07:37:42.517Z
SHA-256 of the archived text
72c47b91f1cd2f0766e707100cd65a9aec33b7ffb53577aeecd98f4ebe34cbe1
Stable URL of this page
https://metraipolis.com/documento/dc_caf9e60bf478

How to cite

Impact evaluation of the Hypertension Treatment in Nigeria program using the Translational Science Benefits Model — Europe PMC PMID:42534330 — Europe PMC (en), https://europepmc.org/article/MED/42534330 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_caf9e60bf478 (Metraipolis archive dc_caf9e60bf478, sha256 72c47b91f1cd2f0766e707100cd65a9aec33b7ffb53577aeecd98f4ebe34cbe1)
BibTeX
@misc{dccaf9e60bf478,
  title = {Impact evaluation of the Hypertension Treatment in Nigeria program using the Translational Science Benefits Model — Europe PMC PMID:42534330},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42534330},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_caf9e60bf478; sha256 72c47b91f1cd2f0766e707100cd65a9aec33b7ffb53577aeecd98f4ebe34cbe1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42534330. Agents can read the archived copy with the MCP tool read_document.